CORT Intrinsic Valuation and Fundamental Analysis - Corcept Therapeutics Inc

	Corcept Therapeutics Inc NASDAQ:CORT	US
H	Huntington Ingalls Industries Inc F:HI4	US

Intrinsic Value

The intrinsic value for Corcept Therapeutics Inc (CORT) under the Base Case is 60.75 USD. Compared with the current market price of 86.95 USD, the stock appears Overvalued by 30% .

DCF Value

$67.26

Multiples-Based Value

$54.24

DCF Value

$67.26

Multiples-Based Value

$54.24

Both DCF and multiples point to overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

CORT Intrinsic Value

Overvaluation 30%

Intrinsic Value

Price $86.95

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value $48.6

Get notified when the price drops into your buy zone

Current Price $86.95

Intrinsic Value $60.75

Margin of Safety 20% $48.6

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Corcept Therapeutics Inc.

Explain Valuation